CINtec PLUS Cytology

FDA Premarket Approval P190024 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceCINtec PLUS Cytology
Generic NameImmunocytochemistry Assay, P16/ki-67
ApplicantVentana Medical Systems, Inc.1910 E Innovation Park Drivetucson, AZ 85755 PMA NumberP190024 Supplement NumberS009 Date Received01/03/2023 Decision Date01/30/2023 Product Code QKF  Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2023-01-03
Decision Date2023-01-30
PMAP190024
SupplementS009
Product CodeQKF 
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductNo
Applicant AddressVentana Medical Systems, Inc.
1910 E Innovation Park Drive
tucson, AZ 85755 PMA NumberP190024 Supplement NumberS009 Date Received01/03/2023 Decision Date01/30/2023 Product Code QKF  Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Changes To A Manufacturing Process.

Supplemental Filings

Supplement NumberDateSupplement Type
P190024Original Filing
S009 2023-01-03 30-day Notice
S008 2022-10-14 30-day Notice
S007 2022-07-12 30-day Notice
S006 2022-02-16 Special (immediate Track)
S005 2022-01-28 135 Review Track For 30-day Notice
S004 2021-03-01 30-day Notice
S003
S002 2020-08-26 Real-time Process
S001 2020-04-28 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
04015630977215 P190024 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.